levothyroxine sodium 200 MCG Oral Capsule
- RxCUI
- 1923050
- RxNorm name
- levothyroxine sodium 200 MCG Oral Capsule
- Display name
- levothyroxine sodium 200 MCG Oral Capsule
- Full name
- levothyroxine sodium 200 MCG Oral Capsule
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:05
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tirosint | LEVOTHYROXINE SODIUM | IBSA Pharma Inc. | 7a7ade79-0165-4e31-b84e-667416c00c7e | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 1923050 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | YARAL Pharma Inc. | d28d7202-1278-0486-e053-2995a90af286 | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 1923050 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 7a7ade79-0165-4e31-b84e-667416c00c7e | levothyroxine sodium 200 MCG Oral Capsule | PSN | 13 | These highlights do not include all the information needed to use TIROSINT® safely and effectively. See full prescribing information for TIROSINT. TIROSINT® (levothyroxine sodium) capsules, for oral use Initial U.S. Approval: 2000 | 20260325 |
| 7a7ade79-0165-4e31-b84e-667416c00c7e | levothyroxine sodium 0.2 MG Oral Capsule | SCD | 13 | These highlights do not include all the information needed to use TIROSINT® safely and effectively. See full prescribing information for TIROSINT. TIROSINT® (levothyroxine sodium) capsules, for oral use Initial U.S. Approval: 2000 | 20260325 |
| 7a7ade79-0165-4e31-b84e-667416c00c7e | levothyroxine sodium 200 MCG Oral Capsule | SY | 13 | These highlights do not include all the information needed to use TIROSINT® safely and effectively. See full prescribing information for TIROSINT. TIROSINT® (levothyroxine sodium) capsules, for oral use Initial U.S. Approval: 2000 | 20260325 |
| d28d7202-1278-0486-e053-2995a90af286 | levothyroxine sodium 200 MCG Oral Capsule | SY | 7 | These highlights do not include all the information needed to use Levothyroxine Sodium capsules safely and effectively. See full prescribing information for Levothyroxine Sodium capsules. Levothyroxine Sodium capsules, for oral use Initial U.S. Approval: 2000 | 20260325 |
| d28d7202-1278-0486-e053-2995a90af286 | levothyroxine sodium 0.2 MG Oral Capsule | SCD | 7 | These highlights do not include all the information needed to use Levothyroxine Sodium capsules safely and effectively. See full prescribing information for Levothyroxine Sodium capsules. Levothyroxine Sodium capsules, for oral use Initial U.S. Approval: 2000 | 20260325 |
| d28d7202-1278-0486-e053-2995a90af286 | levothyroxine sodium 200 MCG Oral Capsule | PSN | 7 | These highlights do not include all the information needed to use Levothyroxine Sodium capsules safely and effectively. See full prescribing information for Levothyroxine Sodium capsules. Levothyroxine Sodium capsules, for oral use Initial U.S. Approval: 2000 | 20260325 |